Director/PDMR Shareholding

October 04, 2018

The Company has received notification from Vulpes Life Sciences Fund ("Vulpes") on 2 October 2018 that it purchased 20,000 Ordinary Shares of 1p in the capital of the Company ("Ordinary Shares") at 3.60p per Ordinary Share (the “Purchase”).  Following the purchase, Vulpes has a total direct and indirect interest in 60,337,088 equivalent to 20.44% of Proteome Sciences' total issued share capital.

Back to News